On December 17, 2015, the seventh subject received their first experimental treatment in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. This subject was enrolled on December 4. Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, in Marin, Calif., this study will treat 18 subjects suffering from anxiety related to a life-threatening disease that is either ongoing or in remission with a possibility of recurrence. “I love being an MDMA psychotherapist,” reports Dr. Wolfson in his Winter 2015 MAPS Bulletin article. “I am profoundly moved by the experiences and changes in heart, mind, and connections that I experience with my subjects as an MDMA-assisted psychotherapy practitioner.” We currently expect all experimental sessions in this study will be completed in late 2016.